Direkt zum Inhalt
Merck

Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix.

British journal of cancer (2013-01-17)
A Mayer, M Höckel, N Schlischewsky, H Schmidberger, L-C Horn, P Vaupel
ZUSAMMENFASSUNG

Experimental studies have established a causal connection between tumour hypoxia, hypoxia-associated proteome changes and downregulation of E-cadherin, the final common pathway of epithelial-to-mesenchymal transition (EMT). Our study aimed at elucidating the interrelationship of these processes in cancers of the uterine cervix in vivo. Tumour oxygenation was assessed in 48 squamous cell carcinomas (SCC) of the uterine cervix using polarographic needle electrodes. The expression pattern of E-cadherin was investigated by immunohistochemistry and western blotting, and was compared with that of the hypoxia-inducible proteins glucose transporter (GLUT)-1 and carbonic anhydrase (CA) IX in biopsy specimens of the oxygenation measurement tracks. The majority of cervical cancers (52%) were E-cadherin positive, with a complete absence of the antigen in only 10% of the tumours. No correlation was found between the level of E-cadherin expression and the oxygenation status (mean pO(2), median pO(2) and hypoxic fractions). In patients showing partial expression of E-cadherin (38%), staining was not preferentially diminished in GLUT-1- or CA IX-positive areas, and loss of E-cadherin occurred independently of tumour cell scattering. Our data provide no evidence in favour of a hypoxia-induced EMT as a mechanistic basis of cervical cancer invasiveness.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, lyophilized powder, ≥2,000 W-A units/mg protein
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, ≥95% (SDS-PAGE), specific activity ≥3,500 W-A units/mg protein, lyophilized powder
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, BioReagent, suitable for GFC marker
Sigma-Aldrich
Karbonanhydraseisozym II aus Rindererythrocyten, lyophilized powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
Carbonic Anhydrase II human, recombinant, expressed in E. coli, buffered aqueous solution
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, For use as a marker in SDS-PAGE
Sigma-Aldrich
Kohlensäureanhydrase I aus Humanerythrocyten
Sigma-Aldrich
Carbonic Anhydrase II bovine, ≥90% (SDS-PAGE), recombinant, expressed in E. coli, ≥5,000 units/mg protein, buffered aqueous solution
Sigma-Aldrich
Carbonic Anhydrase Isozyme II human, ≥80%, powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, non-denaturing PAGE marker
Supelco
Kohlensäureanhydrase I aus Humanerythrocyten, Isoelectric focusing marker, pI 6.6
Sigma-Aldrich
Karbonanhydraseisozym II aus Rindererythrocyten, Isoelectric focusing marker, pI 5.4
Sigma-Aldrich
Karbonanhydraseisozym II aus Rindererythrocyten, lyophilized powder, ≥2,000 W-A units/mg protein